Physician Wealth Advisors’s AnaptysBio ANAB Stock Holding History

Physician Wealth Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.74K	Hold	85	–	–	﹤0.01%	1035
2026 Q1	$4.71K	Hold	85	–	–	﹤0.01%	1024
2025 Q4	$4.12K	Hold	85	–	–	﹤0.01%	1040
2025 Q3	$2.6K	Hold	85	–	–	﹤0.01%	1110
2025 Q2	$1.89K	Buy	85 +31	+57%	+$649	﹤0.01%	1071
2025 Q1	$1K	Buy	+54	New	+$901	﹤0.01%	1057

Other funds holding ANAB

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

DWAM

Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return

Physician Wealth Advisors's ANAB Position: Q2 2026 in Review

Physician Wealth Advisors held its AnaptysBio (ANAB) position steady in Q2 2026 at 85 shares worth $5.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

Physician Wealth Advisors first reported a position in ANAB in Q1 2025 and has held it in 6 quarters since. 38 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Physician Wealth Advisors held 85 shares of AnaptysBio worth $5.74K as of Q2 2026.
Physician Wealth Advisors left its AnaptysBio share count unchanged in Q2 2026.
AnaptysBio made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1035 holding.
Physician Wealth Advisors first reported a position in AnaptysBio in Q1 2025 and has held it in 6 quarters since.
38 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.